RECRUITINGOBSERVATIONAL
Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease
About This Trial
Evaluation of femoral vein wall thickness and inflammatory indices in patients with Behcet disease and assessment of their relation to the disease activity and related some clinical manifestations
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients fulfill the International Criteria for Behcet's Disease (ICBD)
- Age above 18 years old
- Patients cooperative and can answer questions
- Patients who are able and willing to give willing to sign a consent form
Who Should NOT Join This Trial:
- Other rheumatological and vascular diseases
- Patients with abnormal hepatic or renal function tests , hyperlipidemia and impaired coagulation tests
- Patients with hypertension , diabetes mellitus , malignant and active infectious diseases
- Patients who are using aspirin and other platelet active drygs during the previous 6 months
- patients who are not able and willing to give written consent
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients fulfill the International Criteria for Behcet's Disease (ICBD)
* Age above 18 years old
* Patients cooperative and can answer questions
* Patients who are able and willing to give informed consent
Exclusion Criteria:
* Other rheumatological and vascular diseases
* Patients with abnormal hepatic or renal function tests , hyperlipidemia and impaired coagulation tests
* Patients with hypertension , diabetes mellitus , malignant and active infectious diseases
* Patients who are using aspirin and other platelet active drygs during the previous 6 months
* patients who are not able and willing to give written consent
Locations (1)
Sohag university
Sohag, Egypt